Our reviews

Our Reviews

Select stage:(Stage filter not available for Subtopic view)

Full list:

Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis

Alemtuzumab for multiple sclerosis

Amantadine for fatigue in multiple sclerosis

Aminopyridines for symptomatic treatment in multiple sclerosis

Anti-spasticity agents for multiple sclerosis

Azathioprine for multiple sclerosis

Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome

Cannabis and cannabinoids for people with multiple sclerosis

Carnitine for fatigue in multiple sclerosis

Cladribine for people with multiple sclerosis

Conservative interventions for urinary or faecal incontinence, or both, in adults with multiple sclerosis

Corticosteroids for the long-term treatment in multiple sclerosis

Corticosteroids or ACTH for acute exacerbations in multiple sclerosis

Cyclophosphamide for multiple sclerosis

Daclizumab for relapsing remitting multiple sclerosis

Dietary interventions for multiple sclerosis-related outcomes

Dimethyl fumarate for multiple sclerosis

Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis

Exercise therapy for fatigue in multiple sclerosis

Exercise therapy for multiple sclerosis

Fingolimod for relapsing-remitting multiple sclerosis

Glatiramer acetate for multiple sclerosis

Hyperbaric oxygen therapy for multiple sclerosis

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis

Information provision for people with multiple sclerosis

Interferon Beta for Primary Progressive Multiple Sclerosis

Interferon beta for secondary progressive multiple sclerosis

Interferon in relapsing-remitting multiple sclerosis

Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis

Interventions for preventing falls in people with multiple sclerosis

Intravenous immunoglobulin for the treatment of childhood encephalitis

Intravenous immunoglobulins for multiple sclerosis

Laquinimod for multiple sclerosis

Memory rehabilitation for people with multiple sclerosis

Methotrexate for multiple sclerosis

Mitoxantrone for multiple sclerosis

Multidisciplinary rehabilitation for adults with multiple sclerosis

Mycophenolate mofetil for relapsing-remitting multiple sclerosis

Natalizumab for relapsing remitting multiple sclerosis

Neuropsychological rehabilitation for multiple sclerosis

Non pharmacological interventions for spasticity in multiple sclerosis

Non-pharmacological interventions for chronic pain in multiple sclerosis

Occupational therapy for multiple sclerosis

Ocrelizumab for multiple sclerosis

Oral versus intravenous steroids for treatment of relapses in multiple sclerosis

Ozanimod for relapsing-remitting multiple sclerosis

Palliative care interventions for people with multiple sclerosis

Patient education for fatigue in people with multiple sclerosis

Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis

Pharmacologic treatment of depression in multiple sclerosis

Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis

Pharmacological treatment for memory disorder in multiple sclerosis

Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis

Prostaglandin E1 for treatment of erectile dysfunction

Psychological interventions for enhancing adherence to disease-modifying therapies (DMTs) in multiple sclerosis

Psychological interventions for multiple sclerosis

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis

Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews

Respiratory muscle training for multiple sclerosis

Rituximab for people with multiple sclerosis

Rituximab for relapsing-remitting multiple sclerosis

Route of antibiotic prophylaxis for prevention of cerebrospinal fluid-shunt infection

Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis

Siponimod for multiple sclerosis

Sodium channel blockers for neuroprotection in multiple sclerosis

Statins for multiple sclerosis

Telerehabilitation for persons with multiple sclerosis

Teriflunomide for multiple sclerosis

Transcranial direct current stimulation (tDCS) for improving fatigue, motor function, and pain in people with multiple sclerosis

Treatment for ataxia in multiple sclerosis

Treatment of seizures in multiple sclerosis

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

Ventriculo-peritoneal shunting devices for hydrocephalus

Virtual reality for multiple sclerosis rehabilitation

Vitamin D for the management of multiple sclerosis

alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis

By subtopic:

Pharmacological interventions for Multiple Sclerosis (37)

Aminopyridine (1)

Aminopyridines for symptomatic treatment in multiple sclerosis

Alemtuzumab (2)

Alemtuzumab for multiple sclerosis

alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis

Daclizumab for relapsing remitting multiple sclerosis

Natalizumab (1)

Natalizumab for relapsing remitting multiple sclerosis

Ocrelizumab (1)

Ocrelizumab for multiple sclerosis (protocol stage)

Rituximab for people with multiple sclerosis (protocol stage)

Rituximab for relapsing-remitting multiple sclerosis

T-cell vaccination (0)

Immunomodulators (11)

Dimethyl fumarate (1)

Dimethyl fumarate for multiple sclerosis

Glatiramer acetate (1)

Glatiramer acetate for multiple sclerosis

Immunoglobulins (1)

Intravenous immunoglobulins for multiple sclerosis

Interferons: recombinant alpha-2a, recombinant beta-1a and beta-1b (5)

Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis

Interferon beta for secondary progressive multiple sclerosis

Interferon in relapsing-remitting multiple sclerosis

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis

Interferon Beta for Primary Progressive Multiple Sclerosis

Interleukine(s) (0)

Laquinimod for multiple sclerosis

Ozanimod for relapsing-remitting multiple sclerosis (protocol stage)

Plasma Exchange (0)

Siponimod for multiple sclerosis (protocol stage)

Immunotherapies (4)

Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis (protocol stage)

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis

Statins for multiple sclerosis

Oral versus intravenous steroids for treatment of relapses in multiple sclerosis

Corticosteroids for the long-term treatment in multiple sclerosis

Corticosteroids or ACTH for acute exacerbations in multiple sclerosis

Vitamin D for the management of multiple sclerosis

Sodium channel blockers for neuroprotection in multiple sclerosis

Non pharmacological interventions for Multiple Sclerosis (19)

Dietary interventions for multiple sclerosis-related outcomes

Hyperbaric Oxygen (1)

Hyperbaric oxygen therapy for multiple sclerosis

Psychological therapy (2)

Psychological interventions for enhancing adherence to disease-modifying therapies (DMTs) in multiple sclerosis (protocol stage)

Psychological interventions for multiple sclerosis

Rehabilitation (13)

Conservative interventions for urinary or faecal incontinence, or both, in adults with multiple sclerosis (protocol stage)

Exercise therapy for fatigue in multiple sclerosis

Interventions for preventing falls in people with multiple sclerosis

Memory rehabilitation for people with multiple sclerosis

Multidisciplinary rehabilitation for adults with multiple sclerosis

Occupational therapy for multiple sclerosis

Neuropsychological rehabilitation for multiple sclerosis

Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews

Respiratory muscle training for multiple sclerosis

Telerehabilitation for persons with multiple sclerosis

Exercise therapy for multiple sclerosis

Virtual reality for multiple sclerosis rehabilitation (protocol stage)

Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis

Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis

Ventriculo-peritoneal shunting devices for hydrocephalus

Non pharmacological interventions for symptons of Multiple Sclerosis (3)

Chronic pain (1)

Non-pharmacological interventions for chronic pain in multiple sclerosis

Multiple symptoms (1)

Transcranial direct current stimulation (tDCS) for improving fatigue, motor function, and pain in people with multiple sclerosis (protocol stage)

Non pharmacological interventions for spasticity in multiple sclerosis

Palliative Care for Multiple Sclerosis (1)

Palliative care interventions for people with multiple sclerosis

Prognostic models (1)

Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis (protocol stage)

Symptomatic treatments (Pharmacological Interventions) for Multiple Sclerosis (11)

Cognitive problems (1)

Pharmacological treatment for memory disorder in multiple sclerosis

Treatment of seizures in multiple sclerosis

Anti-spastic drugs/interventions (1)

Anti-spasticity agents for multiple sclerosis

Treatment for movement disorder (1)

Treatments/interventions for ataxia/tremor (1)

Treatment for ataxia in multiple sclerosis

Psychological-Emotional problems (1)

Other pharmacological interventions (1)

Pharmacologic treatment of depression in multiple sclerosis

Selective Serotonin Reuptake Inhibitor (SSRI) (0)

Tricyclic antidepressant (0)

Urinary problems (0)

Bowel problems (0)

Dizziness and Vertigo (0)

Amantadine for fatigue in multiple sclerosis

Carnitine for fatigue in multiple sclerosis

Pain and Dysaesthesia (1)

Multiple treatments (1)

Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis (protocol stage)

Protriptyline (0)

Sexual dysfunctions (2)

Prostaglandins (1)

Prostaglandin E1 for treatment of erectile dysfunction

Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis

Cannabis and cannabinoids for people with multiple sclerosis (protocol stage)

Health services for Multiple Sclerosis (2)

Information provision to patients and caregivers (1)

Information provision for people with multiple sclerosis

Patient education programmes (1)

Patient education for fatigue in people with multiple sclerosis (protocol stage)

Physical and transportation barriers (0)

Preventive health care (services) (0)

Rehabilitation services (0)

Outcome Measures (0)

Vaccinations (0)

New and Updated (in the latest issue of the CLib):